中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Recent progress in the discovery of natural inhibitors against human carboxylesterases

文献类型:期刊论文

作者Hou, Jie3; Yang, Ling1; Wang, Dan-Dan1,2; Zou, Li-Wei1,2; Jin, Qiang2; Ge, Guang-Bo2
刊名FITOTERAPIA
出版日期2017-03-01
卷号117页码:84-95
关键词Carboxylesterases Hce1 Hce2 Natural Inhibitors High-throughput Screening
ISSN号0367-326X
DOI10.1016/j.fitote.2017.01.010
文献子类Review
英文摘要Mammalian carboxylesterases (CEs) are important serine hydrolases catalyzing the hydrolysis of ester- or amide-containing compounds into the corresponding alcohols and carboxylic acids. in human, two primary carboxylesterases including hCE1 and hCE2 have been identified and extensively studied in the past decade. hCE1 is known to play crucial roles in the metabolism of a wide variety of endogenous esters, clinical drugs and insecticides, while hCE2 plays a key role in the metabolic activation of anticancer agents including irinotecan and capecitabine. The key roles of hCEs in both human health and xenobiotic metabolism arouse great interest in the discovery of potent and selective hCEs inhibitors to modulate endobiotic metabolism or to improve the outcomes of patients administrated with ester drugs. This review covers the significance and recent progress in the discovery of natural inhibitors against hCEs. The tools for screening and characterization of inhibitors against human CEs, induding traditional LC-based approaches and the newly developed optical substrate-based assays, are summarized and discussed for the first time. Furthermore, the structural information and inhibitory capacities of all reported hCEs inhibitors including fatty acids, flavonoids, tanshinones and triterpenoids have been systematically summarized. All information and knowledge presented in this review will be very helpful for medicinal chemists to develop more potent and highly selective inhibitors against hCEs for potential biomedical applications. (C) 2017 Published by Elsevier B.V.
WOS关键词RATIOMETRIC FLUORESCENT-PROBE ; COMPLEX BIOLOGICAL SAMPLES ; MAMMALIAN CARBOXYLESTERASES ; HUMAN LIVER ; SELECTIVE-INHIBITION ; DRUG DISCOVERY ; BENZIL DIPHENYLETHANE-1,2-DIONE ; UDP-GLUCURONOSYLTRANSFERASE ; INTESTINAL CARBOXYLESTERASE ; ARYLACETAMIDE DEACETYLASE
WOS研究方向Pharmacology & Pharmacy
语种英语
WOS记录号WOS:000395852600015
出版者ELSEVIER SCIENCE BV
源URL[http://cas-ir.dicp.ac.cn/handle/321008/169444]  
专题大连化学物理研究所_中国科学院大连化学物理研究所
通讯作者Hou, Jie; Ge, Guang-Bo
作者单位1.Shanghai Univ Tradit Chinese Med, Shanghai 201210, Peoples R China
2.Chinese Acad Sci, Dalian Inst Chem Phys, Lab Pharmaceut Resource Discovery, Dalian 116023, Peoples R China
3.Dalian Med Univ, Dalian 116044, Peoples R China
推荐引用方式
GB/T 7714
Hou, Jie,Yang, Ling,Wang, Dan-Dan,et al. Recent progress in the discovery of natural inhibitors against human carboxylesterases[J]. FITOTERAPIA,2017,117:84-95.
APA Hou, Jie,Yang, Ling,Wang, Dan-Dan,Zou, Li-Wei,Jin, Qiang,&Ge, Guang-Bo.(2017).Recent progress in the discovery of natural inhibitors against human carboxylesterases.FITOTERAPIA,117,84-95.
MLA Hou, Jie,et al."Recent progress in the discovery of natural inhibitors against human carboxylesterases".FITOTERAPIA 117(2017):84-95.

入库方式: OAI收割

来源:大连化学物理研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。